We and others have presented evidence for a direct interaction between the matrix (MA) domain of the human immunodeficiency virus type 1 (HIV-1) Gag protein and the cytoplasmic tail of the transmembrane envelope (Env) glycoprotein gp41. In addition, it has been postulated that the MA domain of Gag undergoes a conformational change following Gag processing, and the cytoplasmic tail of gp41 has been shown to modulate Env-mediated membrane fusion activity. Together, these results raise the possibility that the interaction between the gp41 cytoplasmic tail and MA is regulated by protease (PR)-mediated Gag processing, perhaps affecting Env function. To examine whether Gag processing affects Env-mediated fusion, we compared the ability of wild-type (WT) HIV-1 Env and a mutant lacking the gp41 cytoplasmic tail to induce fusion in the context of an active (PR ؉ ) or inactive (PR ؊ ) viral PR. We observed that PR ؊ virions bearing WT Env displayed defects in cell-cell fusion. Impaired fusion did not appear to be due to differences in the levels of virionassociated Env, in CD4-dependent binding to target cells, or in the formation of the CD4-induced gp41 six-helix bundle. Interestingly, truncation of the gp41 cytoplasmic tail reversed the fusion defect. These results suggest that interactions between unprocessed Gag and the gp41 cytoplasmic tail suppress fusion.
During or shortly after virus release from the plasma membrane of the infected cell, the human immunodeficiency virus type 1 (HIV-1) protease (PR) cleaves the Gag and Gag-Pol polyprotein precursors to generate the mature Gag and Pol proteins. This PR-mediated processing of Gag and Gag-Pol precursors leads to a striking transformation in virion morphology, a process known as virus maturation. During maturation, noninfectious particles with electron-lucent cores are converted to infectious virions with electron-dense, conical cores (50, 51, 55) . It has been postulated that Gag processing induces conformational changes in the matrix (MA) domain of Gag (25, 44, 59) . Although it has long been appreciated that immature virions are noninfectious (24, 32, 41) , the nature of the infectivity block and the step in virus entry that is affected remain to be determined.
The HIV-1 Env glycoproteins are synthesized as a 160-kDa precursor protein, gp160, which is cleaved by cellular proteases during trafficking to the plasma membrane to generate the mature surface glycoprotein gp120 and the transmembrane glycoprotein gp41. The gp120/gp41 Env glycoprotein complex is incorporated into virus particles during the assembly process. On the mature HIV-1 virion, gp120 and gp41 act in concert to catalyze the fusion of viral and target cell membranes, resulting in the delivery of the viral core into the cytoplasm. Env-mediated fusion takes place in a series of steps: binding of gp120 to the HIV-1 receptor CD4, interaction between gp120 and a coreceptor (typically CXCR4 or CCR5), formation of a gp41 ectodomain six-helix bundle (6HB), hemifusion, and fusion pore formation (2, 16, 21) .
A number of studies have provided evidence for a functional interaction between the long cytoplasmic tail (CT) of gp41 and the MA domain of Gag. (i) Deletions (57) and point mutations (22) in MA block Env incorporation into virus particles. (ii) Truncation of the gp41 CT reverses the Env incorporation defect imposed by MA mutations (20, 22, 37) . (iii) An Env incorporation defect resulting from a small deletion near the middle of the gp41 CT is reversed by a specific point mutation in MA (38) . In addition, we and others found that viral cores prepared from PR Ϫ virions contained high levels of Pr55
Gag and gp41 (58; T. Murakami and E. O. Freed, unpublished data). Interestingly, this detergent-resistant interaction between gp41 and Pr55 Gag is dependent on the gp41 CT, again suggesting that the CT is required for the Gag-gp41 interaction. Furthermore, several lines of evidence suggest a connection between the CT of retroviral Env glycoproteins and membrane fusion. For example, in the case of certain retroviruses (e.g., murine leukemia virus and Mason-Pfizer monkey virus), the Env CT is cleaved by the viral PR after virus release, and this cleavage event activates Env fusogenicity (5, 42, 43) . In addition, truncation of the CT of the maedi-visna virus (58), simian immunodeficiency virus (SIV) (45, 49, 60) , HIV-1 (13, 15, 20, 54) , and human T-cell leukemia virus type 1 (31) transmembrane glycoproteins increases fusion activity. Together, these observations raise the possibility that interactions between HIV-1 Gag and the gp41 CT may affect Env-mediated fusion and that fusion could thus be influenced by the state of Gag processing.
In this study, we investigated whether Gag processing and virion maturation affect HIV-1 Env-mediated membrane fu-sion. We found that inactivating HIV-1 PR suppresses the ability of HIV-1 virions to induce cell-to-cell fusion, a type of fusion known as fusion from without (3, 11, 28) . The fusion defect is not the result of differences in gp120/gp41 levels on PR ϩ versus PR Ϫ virions and appears to be imposed at a step following CD4 binding and receptor-activated conformational changes in gp41. Interestingly, the fusion defect is reversed by truncating the CT of gp41, suggesting that interactions between unprocessed Gag and the gp41 CT suppress fusion. PR ؊ virions bearing WT Env display defects in cell-cell fusion assays. To examine whether Gag processing affects HIV-1 Env-mediated fusion, we compared the ability of HIV-1 virions to induce fusion from without (11) in the context of either active (PR ϩ ) or inactive (PR Ϫ ) viral PR (27) . To prevent productive infection and thereby ensure that our assays accurately measure fusion from without, we used pseudovirions produced by cotransfecting an Env-defective HIV-1 NL4-3 molecular clone (NL4-3/KFS) (19, 22) or its PR Ϫ counterpart (NL4-3/PR Ϫ /KFS) with a wild-type (WT) NL4-3 Env expression vector. Concentrated pseudovirions were added to a Jurkat T-cell line, and the extent of fusion was determined by scoring syncytia (whose diameters were more than four times those of unfused Jurkat cells). PR ϩ virions efficiently induced fusion; in contrast, fusion induced by PR Ϫ virions was reduced by 90% compared with levels observed with PR ϩ virions (Fig.  1) . We postulated that if the fusion defect observed with PR Ϫ virions was a consequence of interactions between unprocessed Gag and the gp41 CT, then the suppressive effect on fusion would be reversed by removing the CT. To test this hypothesis, we prepared PR ϩ and PR Ϫ pseudovirions bearing an Env mutant (CTdel-144) lacking the CT. This mutant was constructed by introducing two adjacent stop codons in the env gene, such that a truncated form of gp41 lacking the C-terminal 144 amino acids was expressed (39) . Intriguingly, and consistent with our hypothesis, pseudovirions bearing the CTdel-144 Env induced fusion in both PR ϩ and PR Ϫ contexts (Fig.  1) . We obtained results essentially identical to those presented in Fig. 1 by using a highly quantitative fusion assay in which Tat-expressing Jurkat (i.e., Jurkat-tat) cells (6) and LuSIV cells containing a luciferase reporter gene under the control of the SIV long terminal repeat (46) were cocultivated in the presence of concentrated pseudovirions (data not shown). These results support the hypothesis that Gag processing activates virus-induced cell-cell fusion mediated by the WT HIV-1 Env.
Differences in the ability of PR ؉ versus PR ؊ virions to induce fusion are not attributable to different levels of virionassociated Env. To explore the possibility that PR Ϫ virions are fusion defective due to reduced levels of virion-associated Env, we measured levels of gp41 on PR ϩ and PR Ϫ virions by Western blotting. Amounts of virion-associated gp41 were found to be unaffected by whether the virions were PR ϩ or PR Ϫ ; this result was observed for both the WT Env and the CTdel-144 truncation mutant (Fig. 2) . We also determined by radioimmunoprecipitation analysis that the state of Gag processing did not affect gp120 levels on virions bearing either WT or CTdel-144 Env (data not shown). Thus, differences in the ability of PR ϩ and PR Ϫ virions to induce fusion from without do not result from different levels of virion-associated Env.
The fusion defect displayed by PR ؊ virions is not due to impaired CD4-dependent cell surface binding or major effects on 6HB formation. To investigate which step in virus entry is blocked in the absence of Gag processing, we examined whether Gag processing affects CD4-dependent HIV-1 binding to target T cells. For this purpose, we selected the Molt-4 T-cell line (30) , which has been reported to contain low levels of heparan sulfate (40) and therefore displays limited CD4-independent virion binding. Molt-4 cells were incubated (37°C for 30 min) with concentrated HIV-1 pseudovirions in the presence of anti-CD4 monoclonal antibody (MAb) (Beckman 13B8.2) or control immunoglobulin G1 (IgG1). The virusbound cells were stained with a rat anti-gp120 MAb (W#10) recognizing RIQRGPG (Y. Tanaka, unpublished data), and the amount of bound virus was determined by flow cytometry. Pseudovirions bearing WT NL4-3 Env showed comparable levels of CD4-dependent binding (about 95% of total binding) to Molt-4 cells in either the PR ϩ or PR Ϫ context. Pseudovirions bearing CTdel-144 Env displayed a slight, statistically insignificant increase (P ϭ 0.19, t test) in binding in the PR Ϫ context (Fig. 3) . These results indicate that the fusion defect displayed by PR Ϫ virions is not due to differences in CD4-dependent binding to the surface of target cells.
It has been demonstrated that Env-CD4 binding triggers a series of conformational changes in gp120 and gp41 that ultimately lead to the formation of a 6HB in the ectodomain of gp41 (16) . To investigate the possibility that receptor-activated formation of the 6HB is blocked in the absence of Gag pro-
FIG. 1. PR
Ϫ virions display a fusion defect in a cell-cell fusionfrom-without assay. env-defective HIV-1 NL4-3 (NL4-3/KFS) (19, 22) and its PR Ϫ counterpart were cotransfected into 293T cells with pUC19, with vectors expressing the WT NL4-3 Env (pIIINL4env) (39) or the CT truncation mutant CTdel-144 (pNL4envCTdel-144) (39) . Virus-containing supernatants were harvested 2 days posttransfection, and virions were concentrated (10 to 20ϫ) by centrifugation (20,000 ϫ g for 2 h). The concentrated pseudovirions were added to Jurkat cells. After a 20-h cultivation, the number of syncytia (whose diameters were more than four times those of unfused Jurkat cells) was scored. cessing, immunoprecipitation assays were performed using intact HIV-1 virions incubated with an anti-6HB antiserum (rabbit serum no. 948, kindly provided by C. Weiss, U.S. Food and Drug Administration) (12, 23) or control preimmune serum in the presence or absence of soluble CD4 (sCD4) (Fig. 4 ). The immunoprecipitated material was then subjected to Western blotting with the anti-gp41 MAb T32 (kindly provided by P. Earl, National Institute of Allergy and Infectious Diseases) (14) . As previously reported (12), sCD4, by using intact Envexpressing cells, enhanced (by 2.5-fold) immunoprecipitation of gp41 by the anti-6HB Ab (Fig. 4A, lanes 2 and 3, and Fig.  4C ). An enhanced (2.7-fold) immunoprecipitation was also induced by sCD4 in PR Ϫ virions bearing WT NL4-3 Env (Fig.  4A, lanes 6 and 7, and Fig. 4C ). For CTdel-144, reactivity to the anti-6HB Ab was enhanced slightly (1.4-fold) by sCD4 in the PR ϩ context (Fig. 4B, lanes 2 and 3, and Fig. 4C ), whereas there was no substantial enhancement by sCD4 in PR Ϫ virions (Fig. 4B, lanes 6 and 7, and Fig. 4C ). We also assessed the extent of 6HB formation by calculating the fraction of virionassociated gp41 detected by the anti-6HB Ab following sCD4 treatment versus total virion-associated gp41 (Fig. 4D) . Again, the CTdel-144 mutant showed an increase in 6HB formation relative to WT. Reproducible but statistically insignificant reductions in 6HB formation were seen for both WT and CTdel-144 Env in the PR Ϫ context. Together, these results suggest that the fusion defect displayed by PR Ϫ virions is not due to a block in 6HB formation. However, at this time we cannot exclude the possibility that the anti-6HB immunoprecipitation approach used here might not detect small but meaningful differences in formation of the 6HB.
Conclusions. In the present study, we hypothesized that the MA-gp41 CT interaction may be altered by Gag processing, perhaps affecting Env function. Indeed, we found that inactivating HIV-1 PR suppresses Env-mediated cell-cell fusion from without. The fact that the fusion defect is rescued by truncating the gp41 CT suggests that interactions between unprocessed Gag and the gp41 CT inhibit fusion. These results demonstrate a heretofore unappreciated role of the viral PR in activating infectivity and suggest that a fusion defect imposed by unprocessed Gag may contribute to the high degree of potency displayed by PR inhibitors.
How might MA-gp41 interactions suppress membrane fusion? We and others have observed a detergent-resistant association between Pr55
Gag and gp41 in immature (PR Ϫ ) HIV-1 virions (56; Murakami and Freed, unpublished) . This detergent-resistant Gag-gp41 interaction is not detected in mature (PR ϩ ) particles. We speculate that a physical association between Gag and the gp41 CT locks the Env glycoprotein complex into a nonfusogenic conformation that is reversed by PR-mediated Gag processing or by gp41 mutations that eliminate the Gag-gp41 interaction. Interestingly, previous reports suggested that the association between matrix proteins and the CT of envelope proteins may negatively regulate the fusogenicity of measles and Newcastle disease viruses (7, 8, 47) . Taken together, it can be postulated that a variety of enveloped viruses have evolved mechanisms, including MA-Env interactions and PR-mediated Env CT cleavage (5, 42, 43) , to suppress Env-induced membrane fusion until virus budding has been completed. Such mechanisms would limit fusion-induced cytopathicity and abortive reinfections.
To define the step in the fusion process inhibited by unprocessed Gag, we first determined that the state of the viral PR does not affect levels of virion-associated Env. This conclusion is in agreement with that of a previous biochemical report (35) and with morphological and structural analyses of both mature and immature HIV-1 virions by cryoelectron microscopy, which revealed a comparable density of Env proteins on both types of virions (4, 53) . Next, we examined whether Gag processing affects virus binding to target CD4 ϩ T cells. We observed that Env proteins on PR Ϫ virions are functionally competent in the attachment step. Finally, we tested whether 6HB formation takes place to a comparable extent on PR ϩ versus PR Ϫ virions. 6HB formation occurs during membrane fusion induced by a number of different viral glycoproteins, including those of HIV-1 (16, 48) , and several lines of evidence suggest that this structure directly participates in fusion (29, 36, 52) . Our results suggest that the enhanced immunoprecipitation by anti-6HB antibodies induced by sCD4 treatment in virions bearing WT NL4-3 Env is not affected by the state of Gag processing, though the inherent variability in the detection assay would make subtle differences difficult to measure. Interestingly, relative to WT Env, CTdel-144 mutant Env appears to be highly reactive with the anti-6HB Ab even without sCD4 treatment. This phenomenon may in part explain why CD4-independent isolates often acquire CT truncations (17, 26, 34) . Indeed, Edwards et al. recently reported that truncation of the gp41 CT enhances not only binding of monoclonal antibodies to CD4-induced epitopes in the ectodomain of gp120 but also neutralization sensitivity to HIV-1-positive serum (18) . Thus, our results suggest that the fusion defect observed with PR Ϫ virions is elicited at a step following 6HB formation, e.g., hemifusion or the initiation and enlargement of the fusion pore. Gag processing may be necessary for the FIG. 4 . PR ϩ and PR Ϫ virions display comparable levels of 6HB formation. Concentrated HIV-1 virions (prepared as described in the legend of Fig. 1 , except that in this case NL4-3 [1] and CTdel-144 [39] and their PR Ϫ counterparts were used) were incubated with an anti-6HB antiserum (rabbit serum no. 948) or preimmune serum (pre) in the presence or absence of 1 g of sCD4 (Immuno Diagnostics) at 37°C for 2 h. Virions were then pelleted by centrifugation (20,000 ϫ g for 2 h) prior to lysis and immunoprecipitation with protein G Sepharose beads. The immunoprecipitated material was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and subjected to quantitative Western blotting with the anti-gp41 MAb T32. An amount of viral lysate equivalent to input virus was run as a positive control. Gels were run for WT Env (A) and CTdel-144 Env (B). The increase in anti-6HB reactivity (n-fold) induced by sCD4 in the PR assembly of the higher-order Env oligomers that are postulated to be required for fusion (9, 19, 33) . Given the low level of gp120 and gp41 on the surface of HIV-1 virions (10), Env trimers must presumably be free to diffuse and cluster in the plane of the lipid bilayer in order to form fusion-active, higherorder complexes. Interactions between the gp41 CT and unprocessed Gag may limit the ability of Env trimers to diffuse in the plane of the lipid bilayer, thereby inhibiting fusion pore formation. It is also possible that PR-mediated Gag processing and concomitant reorganization of the structure of the mature virion may affect the interaction of Env with lipids or other components of the viral (or cell) membrane, thereby in some manner activating membrane fusion. Alternatively, one of the mature Gag proteins could directly or indirectly influence the fusion reaction.
In summary, we describe here a fundamentally novel observation regarding the functional relationship between the HIV-1 Gag and Env proteins. Work is ongoing in our laboratories to further define the ability of Gag to regulate Env function and the implications of this regulation to our understanding of HIV-1 replication and the development of antiviral agents.
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